Meet the editor

Born in Graz, Austria, Prof. Bernhard Resch received his medical degree at the University of Graz in 1988. Following post-doctoral studies at the Division of Neonatology and the Department of Pediatric Surgery at the University Hospital Graz, he became consultant of Pediatrics in 1997 and consultant of Neonatal and Pediatric Intensive Care Medicine in 2000. Since 2004 he has served as Associate Professor of Pediatrics, and since 2008 he has

served as head of the research unit of Neonatal Infectious Diseases and Epidemiology of the Medical University Graz. In 2012 he graduated as Professor of Pediatrics and in 2013 he became Deputy Head of the Division of Neonatology of the Medical University of Graz. His main research fields include neonatal infectious diseases and periventricular leukomalacia of the preterm infant.

He is a member of the Austrian Society of Pediatrics and Adolescent Medicine (ÖGKJ), the European Society of Pediatric Infectious Diseases (ESPID), and the Austrian Society of Perinatal Medicine (ÖGPPM; president from 2012 to 2014). He was also head of the Austrian Working Group of Neonatology and Pediatric Intensive Care Medicine from 2009 to 2011. Dr. Resch is an associate and academic editor of several SCI-listed journals including *BMC Infectious Diseases*, *Medicine*, and *Frontiers in Pediatrics*. Dr. Resch is married and has four children aged 19 to 29 years.

Contents

**Section 1**

**Section 2**

**Section 3**

Heart Disease

**Section 4**

*by Maja Daurach and Ina Michel-Behnke*

*by Debra T. Linfield and Fariba Rezaee*

*and Muhammad Usman*

*by Muhammad Shafique, Muhammad Asif Zahoor,* 

Viral and Host Factors *by Julian P. Legg*

**Preface III**

RSV Immunology **1**

**Chapter 1 3**

RSV and Late Preterm Infants **27**

**Chapter 2 29**

RSV and Congenital Heart Disease **45**

**Chapter 3 47**

RSV Prophylaxis **59**

**Chapter 4 61**

**Chapter 5 77**

Respiratory Syncytial Virus Infections among Children with Congenital

RSV: Available Prophylactic Options and Vaccines in Clinical Trials

Hurdles in Vaccine Development against Respiratory Syncytial Virus

*Muhammad Imran Arshad, Bilal Aslam, Abu Baker Siddique, Muhammad Hidayat Rasool, Muhammad Usman Qamar*

Disease Severity in Respiratory Syncytial Virus Infection: Role of

Resolving the Debate on RSV Prophylaxis in Late Preterm Infants *by Bosco Paes, Barry Rodgers-Gray and Xavier Carbonell-Estrany*
